Table 1.

Clinical features of PBL cases

Patient #	Case 1	Case 2	Case 3	Case 4	Case 5	Case 6	Case 7	Case 8
Age	59	58	52	20	33	43	52	51
Gender	Female	Male	Male	Male	Male	Male	Female	Male
Primary site (s)	Nasopharynx	Parotid mass/ Mandible	Iliac fossa mass	Skin/LNs	Neck masses /LNs	LNs	Ovary	Maxillary bone/tissue
Lymph nodes involvement	No	Yes	Yes	Yes	Yes	Yes	Yes	No
Other Organs involved	CNS	Spleen	Lungs	CNS	Spleen	Spleen	GIT	No
	Multiple bone	Liver		Liver	Liver	Liver
		Lungs				Lungs
B-symptoms	Yes	Yes	No	Yes	Yes	Yes	Yes	No
HIV status	─	─	─	─	─	+	─	+
BM involvement	+	─	+	+	─	+	+	ND
Stage	IV	IV	IV	IV	IV	IV	IV	I
Lytic lesions	Yes	No	No	No	No	Yes	Yes	No
M protein	IgG	─		IgM	─	─	─	─
CSF cytology	─	─	─	─	─	─	─	─
Therapy	CHOP-R	ESHAP	CHOP-R	Bortezomib	ESHAP	Palliative	Palliative	CHOP-R
	Radiotherapy			Dexamethasone
Response to chemotherapy	Partial	No	Partial	No	Partial	N/A	N/A	Partial
Outcome	Died of disease	Died of disease	Died of disease	Died of disease	Died of disease	Died of disease	Died of disease	Died of disease
Survival time (months)	12	3	9	1	7	2	4	13

ND Not done, N/A Not applicable